|
SMC1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.71271893836911E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.85719994938438E-10 |
| Normal-vs-Stage2 |
7.376900E-04 |
| Normal-vs-Stage3 |
3.00820479637309E-11 |
| Normal-vs-Stage4 |
9.44677669423299E-12 |
| Stage1-vs-Stage2 |
1.632200E-01 |
| Stage1-vs-Stage3 |
7.424200E-02 |
| Stage1-vs-Stage4 |
1.862890E-03 |
| Stage2-vs-Stage3 |
1.702370E-02 |
| Stage2-vs-Stage4 |
2.042400E-03 |
| Stage3-vs-Stage4 |
2.010800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.8515966537791E-11 |
| Normal-vs-AfricanAmerican |
6.595600E-04 |
| Normal-vs-Asian |
5.51239999979636E-07 |
| Caucasian-vs-AfricanAmerican |
5.198400E-01 |
| Caucasian-vs-Asian |
9.957800E-01 |
| AfricanAmerican-vs-Asian |
5.562000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.99680288865056E-15 |
| Normal-vs-Female |
1.06349999917654E-08 |
| Male-vs-Female |
1.69531055860261E-12 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.74390002438685E-09 |
| Normal-vs-Age(41-60Yrs) |
2.65509836339106E-11 |
| Normal-vs-Age(61-80Yrs) |
4.83100004444736E-09 |
| Normal-vs-Age(81-100Yrs) |
4.386100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.840000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.784400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.432600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.922600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.720800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.901200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.308300E-02 |
| Classical-VS-Follicular |
5.762800E-01 |
| Classical-VS-Other |
2.992200E-02 |
| Classical-VS-Normal |
1.52019952182059E-10 |
| Tall-VS-Follicular |
6.988300E-02 |
| Tall-VS-Other |
2.721400E-01 |
| Tall-VS-Normal |
2.55499998935704E-09 |
| Follicular-VS-Other |
8.711600E-02 |
| Follicular-VS-Normal |
1.73550000037714E-07 |
| Other-VS-Normal |
8.04320000000747E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.96179994261092E-10 |
| Normal-vs-N1 |
1.02219999131847E-09 |
| N0-vs-N1 |
7.522300E-02 |
|
|
